Work

Abstract LB357: Preclinical evaluation of ARTS-876, an AKR1C3-activated prodrug targeting KEAP1/NFE2L2-mutant NSCLC

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-lb357

Authors: Cong Zhu, Jiaqi Liang, Xiaozhi Yang, Yin Pan, Wenheng Liang, Xiaobin Zhang, Nathan Schomer, Xiang Zhai, Lina Gu, Qing Sheng, Yaoyu Chen, Fang Li

Language: English

Topic: Genomics, phytochemicals, and oxidative stress

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154692082

Cites:

Cited by:

Related to: